Pharmaceutical launches are data-intensive, but delays in synthesizing early commercial signals hinder real-time resource reallocation decisions. Databricks Genie gives commercial leaders instant, natural language access to their full launch data for fast, accurate decision-making.
JUNE 15–18|SAN FRANCISCO
Join us at the world’s largest data, apps and AI event.
Industry Outcomes: The first quarter of a pharmaceutical launch sets the trajectory for the entire product lifecycle. The data to optimize it is flowing from day one: the question is how fast your team can act on it.
by Adam Crown
Commercial Launch Intelligence & Market Access Analytics
How can timely, precise lab data improve decision-making across the medicine lifecycle? Download this whitepaper to explore how…
Doceree has bold ambitions to bring a new software category to pharma brand teams, one that reshapes campaign deployment in the…
Bristol Myers Squibb is the latest large pharma company to be making a major bet on artificial intelligence,
As biologics have come to supersede small molecules in the biopharma industry’s pipeline, the mounting complexity behind the…
AI is rapidly moving from experimentation to real-world application in early drug discovery. But where does it truly add value…
In an industry where 90 percent of drug candidates fail before reaching the market, a handful of startups are betting everything…
